DGII vs REGN · P/E 60, rev $430.2M vs P/E 14, rev $4.29B
Digi International Inc (DGII) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Digi International Inc (DGII) is a communication equipment company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DGII revenue for 2025-09-30 was $430.2M. Net income was $40.8M. DGII currently screens at market cap $2.56B and trailing P/E 60.1.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DGII currently screens at market cap $2.56B and trailing P/E 60.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DGII and REGN stock pages for the full models.
Not investment advice.